Company / Shares Outstanding
Arrowhead Pharmaceuticals Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
124.4M
FY2025
5-year range
102.4M / 124.4M
FY2021-FY2025
Trend
+15.9%
vs FY2024
Sector context
#84 of 212
Health Care
What the data says
At 124376000.00, Arrowhead Pharmaceuticals's shares outstanding ranks #129 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 59544677.00 in FY2016 to 124376000.00 in FY2025.
Based on SEC 10-K filings.
124376000.00 in FY2025 with a 5-year CAGR of +5.4%.
Increased from 105960000.00 to 124376000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +6.0%
- 5-Year CAGR
- +5.4%
- 10-Year CAGR
- -
Sector benchmark
#129 of 212 in Health CareTop 60% of 212This company 124.4M Sector average 306.7M
▼
-59.4% below sector average
Key checks
Key Insights
- Arrowhead Pharmaceuticals's shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 15.9% year-over-year.
- Ranks #84 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 124.4M | +15.9% |
| FY2024 | 107.3M | +1.3% |
| FY2023 | 106.0M | +1.6% |
| FY2022 | 104.3M | +1.9% |
| FY2021 | 102.4M | +7.2% |
| FY2020 | 95.5M | +7.9% |
| FY2019 | 88.5M | +18.3% |
| FY2018 | 74.8M | +7.2% |
| FY2017 | 69.7M | +17.1% |
| FY2016 | 59.5M | +8.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026